Intelligence · Clinical Pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
- Programs
- 5,427
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
-
Berotralstat, Orladeyo 150 mg hard capsules, Berotralstat, Berotralstat, Berotralstat
Lacuna Pharma Pty Ltd
Hereditary Angioedema (HAE)
1 trial -
Betahistine dihydrochloride, BETASERC 24 mg, comprimé
Lacuna Pharma Pty Ltd
Menière's disease
1 trial -
Betamethasone Microsphere (DE-102) Low Dose
Santen Oy
Diabetic Macular Edema
1 trial -
Bevacizumab
Hoffmann-La Roche
B-cell Lymphoma
1 trial -
Bevacizumab
Hoffmann-La Roche
Breast Cancer
1 trial -
Bevacizumab
Pfizer
Renal Cell Carcinoma
1 trial -
Bevacizumab
Hospital Authority, Hong Kong
Proliferative Diabetic Retinopathy
1 trial -
Bevacizumab
Samsung Bioepis NL B.V.
Lung Cancer
1 trial -
Bevacizumab-Pfizer
Pfizer
Non-Small Cell Lung Cancer
1 trial -
Bexicaserin, LP352 (bexicaserin) Placebo Oral Solution
Lacuna Pharma Pty Ltd
Dravet Syndrome
1 trial -
Bexotegrast, Placebo matching PLN-74809
PLIANT THERAPEUTICS, INC.
Idiopathic pulmonary fibrosis (IPF)
1 trial -
Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed)
GlaxoSmithKline
Invasive meningococcal disease (IMD)
1 trial -
Bexsero suspension for injection in pre-filled syringe Meningococcal group B Vaccine (rDNA, component, adsorbed), Trumenba suspension for injection in pre-filled syringe Meningococcal group B vaccine (recombinant, adsorbed)
Pari Pharma GmbH
Asplenia
1 trial -
Beyfortus 100 mg solution for injection in pre-filled syringe, Beyfortus 50 mg solution for injection in pre-filled syringe, Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)
Fondazione Telethon ETS
Respiratory Syncytial Virus (RSV)
1 trial -
Bias retraining
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Use Disorder
1 trial -
Bictegravir
Gilead Sciences Ireland UC
HIV-1-infection
2 trials -
Bifeprunox
H. Lundbeck A/S
Schizophrenia
1 trial -
Biktarvy 50 mg/200 mg/25 mg film-coated tablets, PTM ISL/LEN, ISLATRAVIR/LENACAPAVIR, ISLATRAVIR/LENACAPAVIR, PTM Biktarvy
Gilead Sciences Pty Limited
HIV-1 Infection
1 trial -
Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obsessive Compulsive Disorder
1 trial -
Bimatoprost SR
AbbVie Deutschland GmbH & Co. KG
Open-angle Glaucoma, Ocular Hypertension
1 trial -
Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 320 mg solution for injection in pre-filled pen, Bimzelx 320 mg solution for injection in pre-filled pen, Placebo matching test. 0.9% sodium chloride solution for injection (unauthorized)., Bimzelx 160 mg solution for injection in pre-filled syringe, Bimzelx 160 mg solution for injection in pre-filled syringe
Lacuna Pharma Pty Ltd
Palmoplantar Pustulosis
1 trial -
BioFoam Surgical Matrix
United Therapeutics Europe Ltd
Intraoperative Bleeding
1 trial -
Biological Therapies Sodium Ascorbate Solution 30 g in 100 mL Injection, SODIUM CHLORIDE
Pari Pharma GmbH
Patient with sepsis complicated by ARDS
1 trial -
Biological/Vaccine
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes
1 trial -
Bion 1301/FUB523
Novartis Pharmaceuticals
IgA nephropathy
1 trial -
Biosteron, 10 mg, tabletki, Senaxa PR, 2 mg, tabletki o przedłużonym uwalnianiu
Lacuna Pharma Pty Ltd
Menopause, sleep disorders in the postmenopausal period
1 trial -
Bipap procedure
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
Bisoprolol Fumarate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Duchenne Muscular Dystrophy
1 trial -
Bisphosphonate
Ultragenyx UK Limited
Osteogenesis Imperfecta
1 trial -
Bitopertin
Disc Medicine
X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)
1 trial -
Bitopertin, Matching Placebo
Disc Medicine
X-Linked Protoporphyria (XLP), Erythropoietic Protoporphyria (EPP)
1 trial -
Blinded CDCA 250 mg TID
Mirum Pharmaceuticals International B.V.
CTX
1 trial -
Bocouture, Placebo excipients (sucrose and human serum albumin) are reconstituted with sterile saline. Placebo vials will have identical appearance as the active product vials.
Merz Therapeutics GmbH
Moderate to Severe Platysma Prominence
1 trial -
Booster Sessions
BRIGHT MINDS BIOSCIENCES INC.
Skill Development of Staff
1 trial -
Bortezomib
Hospital Authority, Hong Kong
Multiple Myeloma
1 trial -
Bortezomib STADA 2,5 mg/ml Injektionslösung, Dexamethason 0,5 mg JENAPHARM®, Empliciti 400 mg powder for concentrate for solution for infusion., Kyprolis 60 mg powder for solution for infusion, Privigen 100 mg/ml solution for infusion, Privigen 100 mg/ml solution for infusion, Imnovid 1 mg hard capsules, -, Nodexon 20 mg tabletes, Imnovid 3 mg hard capsules, Imnovid 4 mg hard capsules, Imnovid 2 mg hard capsules, Nodexon 20 mg tabletės, ELRANATAMAB, Dexamethason 4 mg JENAPHARM®
Pfizer Australia Pty Ltd
Relapsed/Refractory Multiple Myeloma
1 trial -
Bosulif 500 mg film-coated tablets, Olverembatinib, Bosulif 100 mg film-coated tablets
Lacuna Pharma Pty Ltd
Chronic Phase Chronic Myeloid Leukemia
1 trial -
Bosutinib
Pfizer
Chronic Myeloid Leukemia
1 trial -
Botulinum Toxin type A (intradermal / submucosal injection at pain area)
The First People's Hospital of Lianyungang
Trigeminal Neuralgia
1 trial -
Botulinum toxin type A
Hospital Authority, Hong Kong
Obesity
1 trial -
Botulinum toxin type A
Ipsen
Low Back Pain
1 trial -
Breathlessness Support Service
United Therapeutics Europe Ltd
Breathless Patients With Any Established Underlying Medical Diagnosis
1 trial -
Brelovitug (BJT-778)
Mirum Pharmaceuticals International B.V.
Chronic Hepatitis D
1 trial -
Brelovitug 300 mg
Mirum Pharmaceuticals International B.V.
Chronic Hepatitis D Infection
3 trials -
Brentuximab Vedotin
Takeda
Primary Cutaneous Anaplastic Large Cell Lymphoma
1 trial -
Brentuximab Vedotin for Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Classical Hodgkin Lymphoma
1 trial -
Brentuximab vedotin
Pfizer
Diffuse Large B-cell Lymphoma
1 trial -
Brentuximab vedotin
Takeda
Diffuse Large B-cell-lymphoma
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs